Human endogenous retroviruses are poorly annotated intervals of the human genome that may be selectively transcribed in cancers.
Here, we test whether previously unannotated retroviral elements are selectively transcribed in colorectal cancer and could serve as novel biomarkers or, when translated, targets of immunotherapy.
